CR20160307A - Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas - Google Patents

Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas

Info

Publication number
CR20160307A
CR20160307A CR20160307A CR20160307A CR20160307A CR 20160307 A CR20160307 A CR 20160307A CR 20160307 A CR20160307 A CR 20160307A CR 20160307 A CR20160307 A CR 20160307A CR 20160307 A CR20160307 A CR 20160307A
Authority
CR
Costa Rica
Prior art keywords
compositions
making
methods
same
sample
Prior art date
Application number
CR20160307A
Other languages
English (en)
Inventor
Vincent C Giampapa
Original Assignee
Advanced Regen Medical Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Regen Medical Tech Llc filed Critical Advanced Regen Medical Tech Llc
Publication of CR20160307A publication Critical patent/CR20160307A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un método que comprende obtener una primera muestra de células de un primer individuo; obtener una segunda muestra de células de un segundo individuo; cultivar la primera muestra de células en presencia de al menos una porción de un medio de cultivo de la segunda muestra de células por un periodo con un rango entre aproximadamente 24 horas y aproximadamente 6 semanas para producir una composición restauradora; y poner en contacto la composición restauradora con la segunda muestra de células por un periodo con un rango entre aproximadamente 24 horas y aproximadamente 6 semanas para producir una composición restaurada.
CR20160307A 2013-12-20 2014-12-19 Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas CR20160307A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361919165P 2013-12-20 2013-12-20
PCT/US2014/071667 WO2015095794A1 (en) 2013-12-20 2014-12-19 Compositions for cellular restoration and methods of making and using same

Publications (1)

Publication Number Publication Date
CR20160307A true CR20160307A (es) 2016-11-08

Family

ID=53398909

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160307A CR20160307A (es) 2013-12-20 2014-12-19 Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas

Country Status (5)

Country Link
US (2) US20150174166A1 (es)
EP (1) EP3083939A4 (es)
JP (1) JP6353073B2 (es)
CR (1) CR20160307A (es)
WO (1) WO2015095794A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11286463B2 (en) 2012-03-08 2022-03-29 Advanced ReGen Medical Technologies, LLC Reprogramming of aged adult stem cells
US9994814B2 (en) 2013-04-09 2018-06-12 Advanced ReGen Medical Technologies, LLC Method for cellular restoration
CR20160307A (es) 2013-12-20 2016-11-08 Advanced Regen Medical Tech Llc Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas
US10772911B2 (en) 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
WO2017189842A1 (en) * 2016-04-27 2017-11-02 The Scripps Research Institute Extracellular vesicles from young stem cells or serum for age-related therapies
WO2017190000A1 (en) 2016-04-29 2017-11-02 Advanced ReGen Medical Technologies, LLC Microrna compositions and methods of making and using same
US11497708B2 (en) 2016-06-16 2022-11-15 BEMY Cosmetics, Inc. Customized cosmetic compositions, and methods of rejuvenating and utilizing conditioned media and/or components thereof
WO2018089795A1 (en) 2016-11-10 2018-05-17 Qoravita LLC System and method for applying a low frequency magnetic field to biological tissues
KR20200108275A (ko) 2017-12-28 2020-09-17 코디악 바이오사이언시즈, 인크. 면역-종양학 및 항-염증 요법을 위한 엑소좀
US10717981B2 (en) 2018-01-18 2020-07-21 Advanced ReGen Medical Technologies, LLC Therapeutic compositions and methods of making and using the same
JP7320302B2 (ja) * 2018-10-02 2023-08-03 ステムオン インコーポレーテッド 細胞のテロメアを伸長させる組成物およびその製造方法

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2984164A (en) 1955-01-12 1961-05-16 Voigtlaender Ag Automatic exposure adjustment in photographic cameras
US3122333A (en) 1961-02-23 1964-02-25 Gen Mills Inc Tape quantity sensing and winding control apparatus
US3083939A (en) 1961-03-02 1963-04-02 Jr Edward J Gallagher Floating shockproof and vibrationless assembly for delicate instrument panel mount
US3436081A (en) 1967-06-26 1969-04-01 Sandor A Ungar Game equipment
US6319471B1 (en) 1992-07-10 2001-11-20 Gambro, Inc. Apparatus for producing blood component products
US20040199935A1 (en) 1999-06-30 2004-10-07 Chapman Karen B. Cytoplasmic transfer to de-differentiate recipient cells
EP1231956A2 (en) 2000-03-09 2002-08-21 Gambro, Inc. Extracorporeal blood processing method and apparatus
AU2002952944A0 (en) 2002-11-27 2002-12-12 Human Genetic Signatures Pty Ltd Restoration of methylation states in cells
US20080213812A1 (en) 2003-09-29 2008-09-04 Andrews William H Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
US20050158285A1 (en) 2003-12-09 2005-07-21 Giampapa Vincent C. Method of re-profiling adult stem cells using embryonic stem cell electromagnetic signals
US20080268429A1 (en) 2004-06-02 2008-10-30 Sourcepharm, Inc. Rna - Containing Microvesicles and Methods Therefor
WO2006007529A2 (en) 2004-07-01 2006-01-19 University Of Pittsburgh Of The Commonwealth System For Higher Education Immunosuppressive exosomes
US20070196918A1 (en) 2004-07-15 2007-08-23 Sayre Chauncey B Reprogramming of adult human testicular stem cells to pluripotent germ-line stem cells
US20080267921A1 (en) 2004-11-08 2008-10-30 Johns Hopkins University Cardiac Stem Cells
AU2006242225B2 (en) 2005-04-29 2012-01-12 Rockefeller University Human microRNAs and methods for inhibiting same
US20070025973A1 (en) 2005-07-29 2007-02-01 Fitzsimmons Frederick J Reprogramming of adult or neonic stem cells and methods of use
US8945558B2 (en) 2005-10-21 2015-02-03 Chugai Seiyaku Kabushiki Kaisha Methods for treating myocardial infarction comprising administering an IL-6 inhibitor
WO2007133812A2 (en) 2005-12-30 2007-11-22 Philadelphia Health & Education Corporation, D/B/A Drexel University College Of Medicine Improved carriers for delivery of nucleic acid agents to cells and tissues
EP1810686A1 (en) 2006-01-19 2007-07-25 Academisch Ziekenhuis Leiden Means and methods for modulating stem cell mobilization
GB0605450D0 (en) 2006-03-17 2006-04-26 Intercytex Ltd Cell co-culture
KR100832592B1 (ko) 2006-08-17 2008-05-27 박현숙 폴리머 막을 이용한 줄기세포와 피더세포의 공배양방법
KR100959995B1 (ko) 2006-12-01 2010-05-28 메디포스트(주) 인간 제대혈 유래 간엽 줄기세포를 유효성분으로 포함하는,신경전구세포 또는 신경줄기세포의 신경세포로의 분화 및증식 유도용 조성물
US9387226B2 (en) 2006-11-30 2016-07-12 Medipost Co., Ltd Neural cell proliferation induced through the culture of neural cells with umbilical cord blood-derived mesenchymal stem cells
AU2007347449A1 (en) 2007-02-16 2008-08-28 The Johns Hopkins University The microRNAome
US9205112B2 (en) 2007-04-23 2015-12-08 Creative Medical Health, Inc. Combination treatment of cardiovascular disease
WO2009011546A2 (en) 2007-07-16 2009-01-22 Catholic University Industry Academic Cooperation Foundation Method for promoting the self-renewal of adult stem cells using mesenchymal stromal cells
WO2009079592A2 (en) 2007-12-17 2009-06-25 California Institute Of Technology Modulating immune system development and function through microrna mir-146
WO2009086425A1 (en) 2007-12-28 2009-07-09 Fate Therapeutics, Inc. Methods for reprogramming cells to a pluripotent state and therapeutic applications related thereto
PL2254586T3 (pl) 2008-02-22 2015-09-30 Agency For Science Tech And Research Astarstar Cząstki mezenchymalnych komórek macierzystych
US20110177054A1 (en) 2008-06-06 2011-07-21 Derrick Gibbings Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna
US8193161B2 (en) 2008-06-09 2012-06-05 New York Medical College Compositions comprising cardiac stem cells overexpressing specific micrornas and methods of their use in repairing damaged myocardium
JP5230809B2 (ja) 2009-06-25 2013-07-10 株式会社日立メディコ 医用画像撮影装置
US20120258093A1 (en) 2009-08-20 2012-10-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
WO2011029903A1 (en) 2009-09-10 2011-03-17 Flemming Velin Method for the preparation of micro-rna and its therapeutic application
CN102686264A (zh) 2009-10-27 2012-09-19 雪松-西奈医疗中心 用于具有增强的细胞滞留的靶向细胞递送的外部磁力
EP2363136A1 (en) 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
US9249392B2 (en) 2010-04-30 2016-02-02 Cedars-Sinai Medical Center Methods and compositions for maintaining genomic stability in cultured stem cells
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
CA2845280A1 (en) 2010-08-13 2012-02-16 Paul Shiels Therapeutic uses of microvesicles and related micrornas
EP3563858A1 (en) 2010-10-18 2019-11-06 Agency For Science, Technology And Research Use of exosomes to promote or enhance wound healing
US20120093885A1 (en) * 2010-10-18 2012-04-19 Northwestern University Therapeutic vesicles
WO2012087241A1 (en) 2010-12-20 2012-06-28 Agency For Science, Technology And Research Method of purifying exosomes
SG183579A1 (en) 2011-02-11 2012-09-27 Agency Science Tech & Res Methods of detecting therapeutic exosomes
US9241950B2 (en) 2011-04-28 2016-01-26 New York University MiR-33 inhibitors and uses thereof to decrease inflammation
WO2012159044A1 (en) 2011-05-18 2012-11-22 Wellstat Therapeutics Corporation Stem cell mobilization and tissue repair and regeneration
WO2012162741A1 (en) 2011-06-01 2012-12-06 Monash University Enrichment of cardiomyocytes
EP2535412A1 (en) 2011-06-17 2012-12-19 Universitat Pompeu-Fabra New treatment for muscular dystrophies
US8747915B1 (en) 2011-09-14 2014-06-10 Vincent C. Giampapa Dietary supplement system for multifunctional anti-aging management and method of use
WO2013048734A1 (en) 2011-09-28 2013-04-04 Tufts Medical Center, Inc. Treatment and prevention of cardiovascular disease with cell derived lipid vesicles, microvesicles and exosomes
WO2013066368A1 (en) 2011-10-03 2013-05-10 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Use of mirna 126 to produce hematopoietic stem cells
US9315776B2 (en) 2011-11-09 2016-04-19 National University Of Singapore Wharton's jelly mesenchymal stem cells and uses thereof
US9427450B2 (en) * 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
US11286463B2 (en) 2012-03-08 2022-03-29 Advanced ReGen Medical Technologies, LLC Reprogramming of aged adult stem cells
US20150023935A1 (en) 2012-03-08 2015-01-22 Advanced ReGen Medical Technologies, Inc. Reprogramming of Aged Adult Stem Cells
US20130236428A1 (en) 2012-03-08 2013-09-12 Vincent C. Giampapa Reprogramming of Aged Adult Stem Cells
GB201302468D0 (en) 2013-02-12 2013-03-27 Reneuron Ltd Stem cell product
WO2013170170A2 (en) 2012-05-10 2013-11-14 Board Of Regents Of The University Of Nebraska Compositions and methods for gene therapy
US9295696B2 (en) * 2012-06-08 2016-03-29 University of Pittsburgh—of the Commonwealth System of Higher Education Compositions and methods for restoring or rejuvenating stem/progenitor cell function
EP2687219A1 (en) 2012-07-18 2014-01-22 Universität Duisburg-Essen Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
JP2015529450A (ja) 2012-07-19 2015-10-08 リニューロン・リミテッドＲｅＮｅｕｒｏｎ Ｌｉｍｉｔｅｄ 幹細胞微粒子
AU2013302799B2 (en) 2012-08-13 2018-03-01 Cedars-Sinai Medical Center Exosomes and micro-ribonucleic acids for tissue regeneration
CA2882966A1 (en) 2012-08-31 2014-03-06 Aptamir Therapeutics, Inc. Mirna modulators of chronic visceral inflammation
US9492484B2 (en) 2012-09-27 2016-11-15 The Regents Of The University Of California Cardiosphere derived cell population and methods of use
CZ2012678A3 (cs) 2012-10-04 2014-04-16 Primecell A.S. Způsob zpracování odběrů pupečníkové krve, zpracování a uchování získané odpadní pupečníkové krve a její terapeutické využití
US9242000B2 (en) 2012-10-18 2016-01-26 The Regents Of The University Of California Micro-RNAs and micro-RNA inhibitors to modulate blood vessel growth, patterning, tumor growth and malignant disease and method for making and using them
WO2014066545A1 (en) 2012-10-26 2014-05-01 Cedars-Sinai Medical Center Therapeutic cells depleted of specific subpopulations of cells for use in tissue repair of regeneration
US20150367063A1 (en) 2013-02-26 2015-12-24 Terumo Kabushiki Kaisha Blood Component Separation Apparatus
US9994814B2 (en) 2013-04-09 2018-06-12 Advanced ReGen Medical Technologies, LLC Method for cellular restoration
BR112016003053A2 (pt) 2013-08-14 2017-09-12 Reneuron Ltd micropartículas de células tronco e mirna
GB201317889D0 (en) 2013-10-09 2013-11-20 Reneuron Ltd Product and use
US11001809B2 (en) 2013-11-15 2021-05-11 The Mclean Hospital Corporation Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors
HUE046489T2 (hu) 2013-12-04 2020-03-30 Univ Texas Eljárás ráksejtekbõl származó exoszómák izolálására
WO2015148534A1 (en) 2014-03-24 2015-10-01 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
US10772911B2 (en) 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
CR20160307A (es) 2013-12-20 2016-11-08 Advanced Regen Medical Tech Llc Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas
US20160346334A1 (en) 2014-02-05 2016-12-01 Stc.Unm Exosomes as a therapeutic for cancer
US20150328263A1 (en) 2014-05-14 2015-11-19 University Of Maryland, Baltimore Cardiac stem cells for cardiac repair
RU2016152143A (ru) 2014-05-30 2018-07-04 Торэй Индастриз, Инк. Набор или устройство для обнаружения рака поджелудочной железы и способ обнаружения
CA2951008A1 (en) 2014-06-11 2015-12-17 Toray Industries, Inc. Biliary tract cancer detection kit or device, and detection method
KR102401222B1 (ko) 2014-06-13 2022-05-24 국립연구개발법인 고쿠리츠간켄큐센터 유방암 검출 키트 또는 디바이스 및 검출 방법
WO2016054591A1 (en) 2014-10-03 2016-04-07 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
US20170304368A1 (en) 2014-10-06 2017-10-26 Cedars-Sinai Medical Center Polarization of macrophages to a healing phenotype by cardiosphere-derived cells and by the exosomes secreted by such cells
US10624849B2 (en) 2015-09-28 2020-04-21 Northwestern University Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
EP3387131A4 (en) 2015-12-09 2019-08-07 Alnylam Pharmaceuticals, Inc. AGAINST PROGRAMMED CELL DEOD 1 LIGAND 1 (PD-L1) POLYNUCLEOTIDE AGENT AND METHOD OF USE THEREOF
US11253551B2 (en) 2016-01-11 2022-02-22 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
WO2017190000A1 (en) 2016-04-29 2017-11-02 Advanced ReGen Medical Technologies, LLC Microrna compositions and methods of making and using same
WO2019028223A1 (en) 2017-08-04 2019-02-07 Cedars-Sinai Medical Center CARDIOSPHERE-DERIVED CELLS AND THEIR EXTRACELLULAR VESICLES FOR THE TREATMENT AND PREVENTION OF CANCER
US10717981B2 (en) 2018-01-18 2020-07-21 Advanced ReGen Medical Technologies, LLC Therapeutic compositions and methods of making and using the same
US20220220561A1 (en) 2019-03-18 2022-07-14 Advanced ReGen Medical Technologies, LLC Methods and clinical protocols and kits pertaining to making and using therapeutic compositions for cellular treatment

Also Published As

Publication number Publication date
JP6353073B2 (ja) 2018-07-04
US20150174166A1 (en) 2015-06-25
US11219643B2 (en) 2022-01-11
JP2017503019A (ja) 2017-01-26
EP3083939A4 (en) 2017-05-17
WO2015095794A1 (en) 2015-06-25
EP3083939A1 (en) 2016-10-26
US20180360878A1 (en) 2018-12-20

Similar Documents

Publication Publication Date Title
MX2022003477A (es) Medio de cultivo celular complementado con taurina y metodos de uso.
AR090822A1 (es) Composiciones de cultivo de celulas y metodos para la produccion de polipeptidos
EP2373784A4 (en) GENERATION AND CONSERVATION OF STEM CELLS
CO6501191A2 (es) Medio de cultivo celular para expresión de la proteina adamts
TR201904270T4 (tr) Tanımlı koşullar altında insan pluripotent kök hücrelerinin hematoendotelyal farklılaşması için yöntemler ve materyaller.
BR112013001089A2 (pt) composição de meio de cultura e método para cultivar células tronco mesenquimais derivadas de âmnio
MX2019011040A (es) Composiciones y metodos para potenciar la expresion genica.
AR094375A1 (es) Métodos de uso de inhibidores del ciclo celular para modular una o más propiedades de un cultivo celular
MX2018005274A (es) Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t.
BR112014000042A2 (pt) composição, meio de cultura celular, uso de uma composição, e, método para cultivar células
CO6561839A2 (es) Alteracion genómica dirigida
SG196784A1 (en) Stem cell cultures
ES2479542T1 (es) Métodos y composiciones para su uso en terapias celulares
MX2016016076A (es) Composiciones de celulas t mejoradas.
MY171710A (en) Culture medium composition, and method for culturing cell or tissue using said composition
WO2016168890A8 (en) Generation of muscle-lineage cells from stem cells
EP3877415A4 (en) PROCEDURE FOR ALLOGENE TRANSPLANTATION OF HEMATOPOETIC STEM CELLS
EA201391523A1 (ru) Композиции и способы для переноса энергии митохондрий аутологичных герминативных клеток
WO2012126013A3 (en) Method for making pluripotent stem cells
GB201305388D0 (en) Benchmarks for normal cell identification
CL2017001903A1 (es) Composición novedosa para uso en el incremento de eficacia de injerto de células madre hematopoyéticas después del trasplante
IN2014DN11272A (es)
AR095348A1 (es) Medios de cultivo celular y métodos de producción de anticuerpos
EA201791233A1 (ru) Материал стволовых клеток и способ его получения
HK1220404A1 (zh) 用於细胞培养的细胞外基质组合物珠粒